Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

URL has been copied successfully!
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here